Aravive Biologics
Biotechnology, Clinical Trials, Health Care
Founded in 12/10/08
Houston, Texas, United States
For Profit
About Aravive Biologics
Aravive Biologics is a clinical-stage biotechnology company that focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies.
Company Metrics
- Employees: 11-50
- Monthly Visits: 4021
- Tech Stack: 15 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 53600000 USD
- Last Funding: 10000000 USD (Post-IPO Equity)
- Funding Status: IPO
Technology Stack
Aravive Biologics actively uses 15 products in their tech stack.
Market Presence
Industries: Biotechnology, Clinical Trials, Health Care
Headquarters: Houston, Texas, United States
Employees
- Gail McIntyre - Chief Executive Officer (LinkedIn)
- Robert Geller - Chief Medical Officer (LinkedIn)
- Rudy Howard - Chief Financial Officer (LinkedIn)
- Scott Dove - Chief Operating Officer (LinkedIn)